AOD9604: A Metabolic Research Overview
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
- AOD9604 is a lab-made peptide copied from the tail end of human growth hormone, and researchers have studied it as a tool for looking at fat metabolism.
- Most of the data comes from animal and cell studies in the early 2000s, where the fragment was linked to fat breakdown in obese mice, but those results do not reliably carry over to people.
- Human obesity trials did not show meaningful weight loss compared with a placebo at the doses tested, so the human evidence is weak, and online community talk about it is unverified anecdote, not proof.
- It is not approved by the FDA for any human or veterinary use, and nothing about it is medical advice.
- BioRegen supplies AOD9604 strictly as reference material for laboratory and educational research, not for use in humans or animals.
AOD9604 is a lab-made peptide. It is built to copy one small piece of human growth hormone (hGH), the tail end of that natural hormone. Scientists often mention it in studies that look at how the body handles fat. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This page sums up how researchers have described the molecule and where the current evidence stops.
What AOD9604 Is
AOD9604 (sometimes written AOD-9604) is a changed piece of the human growth hormone molecule. It copies just the last few amino acids on the end of that hormone. The letters "AOD" come from early papers that called it an "anti-obesity drug" candidate. Instead of copying the whole hormone, the peptide keeps only that short tail end, which researchers had linked to fat-related activity. In published work it has been used as a tool to study how one small part of a big hormone can act differently from the full hormone. For background on how research peptides are prepared in the lab, see our notes on reconstituting peptides.
Mechanism: What the Research Explores
One big question in AOD9604 research is whether this small piece works the same way as the full growth hormone. Studies listed in PubMed have looked at how the peptide relates to fat burning and fat breakdown (the science words are fat oxidation and lipolysis) in animals. In studies using obese mice, researchers reported that the peptide went along with less weight gain and higher signs of fat breakdown. The same data suggested it did not lock onto the growth hormone receptor in the tests they ran. Other studies looked at how it relates to the beta-3 adrenergic pathway, a signaling system in fat cells. There, researchers saw changes in how much of that receptor the cells made, rather than the peptide binding to it directly. All of these are observations in lab animals and cells. They do not prove anything about what happens in people.
Research Stage and Limitations
Most of the early AOD9604 research comes from animal studies and lab-dish (in vitro) tests done in the early 2000s. Later review papers list it as one of many metabolic compounds still being studied, not settled science. It is worth saying clearly: most of what we know about how it might work comes from rodents and cell tests, and those results often do not carry over to people. The compound is not an approved treatment. BioRegen shares this only as a plain summary of the scientific record, for research and learning. You can also find talk about this peptide in online groups and forums, but treat that as unproven personal stories, not controlled study results. BioRegen does not make or back any claims based on those stories. If you are comparing metabolic research compounds, our comparison of retatrutide, tirzepatide, and semaglutide may help with context.
Handling Notes for the Laboratory
Like most freeze-dried (lyophilized) research peptides, the published guidance is simple: keep the dry powder cold and out of light, and only mix it using proper lab liquids. Once it is mixed into a liquid, it is usually treated as less stable than the dry powder. These are general handling notes from peptide research papers. They are here for lab reference only, not as any kind of use or dosing instruction. To find related research compounds, the research finder can help you narrow your search by category.
Frequently Asked Questions
Is AOD9604 the same as human growth hormone?
No. In published research, AOD9604 is just a short piece copied from the tail end of human growth hormone, not the whole hormone. Studies reported that it did not lock onto the growth hormone receptor in the tests they ran, which is why researchers study it as its own separate molecule.
What have studies focused on?
Most of the research has looked at fat burning, fat breakdown, and related body signals in animals, plus how the peptide relates to certain fat-cell signaling systems. These are lab observations, not proven results in people.
Is AOD9604 approved for use?
No. No compound on this page is approved for use in people or animals. AOD9604 is mentioned here only as a subject of laboratory and educational research.
Selected Research References
- Heffernan MA, et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes Relat Metab Disord. 2001. https://doi.org/10.1038/sj.ijo.0801740
- Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001. https://doi.org/10.1210/endo.142.12.8522
Reference metadata sourced via PubMed.
Planning a research project around metabolic peptides? Explore our research guide for laboratory background, and create a free account for 10% off your first order. You can browse related compounds in our metabolic research category.
This content is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, and nothing here constitutes medical advice or a recommendation for use in humans or animals. BioRegen makes no therapeutic claims of any kind.